Frequently Asked Questions

Cardiovascular

The labeling for ALEVE is consistent with over-the-counter (OTC) nonsteroidal anti-inflammatory drug (NSAID) labeling and includes a warning designed to inform consumers that “when using this product the risk of heart attack or stroke may increase if you use more than directed or for longer than directed.”1

What data are available regarding naproxen/naproxen sodium and cardiovascular (CV) safety?

For information on the CV safety of naproxen/naproxen sodium, please contact us.

Reference:
1. ALEVE label.